Epigallocatechin‐3‐gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Life Science

• Publication date

  2017-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.lfs.2017.10.016PMID 29032114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?

  2017cited by this paper
• Oxidative stress in prostate hyperplasia and carcinogenesis

  2016cited by this paper
• Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats

  2016cited by this paper
• Management of Benign Prostatic Hyperplasia.

  2016cited by this paper
• Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats.

  2016cited by this paper
• Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes

  2016cited by this paper
• Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review

  2016cited by this paper
• What do we know about phytotherapy of benign prostatic hyperplasia?

  2015cited by this paper
• Hypoxia-induced autophagy promotes human prostate stromal cells survival and ER-stress.

  2015cited by this paper
• Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells

  2015cited by this paper
• Histologic evaluation of human benign prostatic hyperplasia treated by dutasteride: a study by xenograft model with improved severe combined immunodeficient mice.

  2015cited by this paper
• Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.

  2015cited by this paper
• EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism

  2015cited by this paper
• Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?

  2015cited by this paper
• Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.

  2014cited by this paper
• Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review

  2014cited by this paper
• Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.

  2013cited by this paper
• The Link Between Benign Prostatic Hyperplasia and Inflammation

  2013cited by this paper
• Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway

  2012cited by this paper
• Studies on Focal Adhesion Kinase in human breast cancer cell MDA-MB-231

  2012cited by this paper
• Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.

  2011cited by this paper
• The functional role of reactive stroma in benign prostatic hyperplasia.

  2011cited by this paper
• Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro

  2011cited by this paper
• Green Tea and Black Tea Consumption and Prostate Cancer Risk: An Exploratory Meta-Analysis of Observational Studies

  2011cited by this paper
• The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

  2011cited by this paper
• Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion

  2010cited by this paper
• Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone‐releasing hormone antagonist cetrorelix

  2010cited by this paper
• Hydrogen peroxide activates focal adhesion kinase and c-Src by a phosphatidylinositol 3 kinase-dependent mechanism and promotes cell migration in Caco-2 cell monolayers.

  2010cited by this paper
• The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF‐kB pathways

  2009cited by this paper
• Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis

  2009cited by this paper
• Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.

  2009cited by this paper
• FYN is overexpressed in human prostate cancer

  2009cited by this paper
• Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.

  2008cited by this paper
• Chronic inflammation in benign prostatic hyperplasia: implications for therapy.

  2008cited by this paper
• Genetic changes and DNA damage responses in the prostate

  2008cited by this paper
• Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells

  2008cited by this paper
• Multitargeted therapy of cancer by green tea polyphenols.

  2008cited by this paper
• Green tea consumption and prostate cancer risk in Japanese men: a prospective study.

  2007cited by this paper
• Epigallocatechin-3-O-Gallate Inhibits the Angiotensin II-Induced Adhesion Molecule Expression in Human Umbilical Vein Endothelial Cell Via Inhibition of MAPK Pathways

  2007cited by this paper
• Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.

  2006cited by this paper
• Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells

  2006cited by this paper
• Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.

  2006cited by this paper
• (−)‐Epigallocatechin‐3‐gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms

  2005cited by this paper
• Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.

  2005cited by this paper
• Focal adhesion kinase inhibitory peptides induce apoptosis in human breast cancer cells

  2004cited by this paper
• Interleukin‐8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia

  2004cited by this paper
• Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer

  2004cited by this paper
• Basal prostate epithelial cells stimulate the migration of prostate cancer cells

  2004cited by this paper
• LIM Kinase 1 Is Essential for the Invasive Growth of Prostate Epithelial Cells

  2003cited by this paper
• The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines.

  2003cited by this paper
• Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.

  2003cited by this paper
• LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer.

  2003cited by this paper
• Cytokine Expression Pattern in Benign Prostatic Hyperplasia Infiltrating T Cells and Impact of Lymphocytic Infiltration on Cytokine mRNA Profile in Prostatic Tissue

  2003cited by this paper
• Expression and function of pro‐inflammatory interleukin IL‐17 and IL‐17 receptor in normal, benign hyperplastic, and malignant prostate

  2003cited by this paper
• Expression of focal adhesion kinase in normal and pathologic human prostate tissues

  2002cited by this paper
• Differential expression of interleukin‐15, a pro‐inflammatory cytokine and T‐cell growth factor, and its receptor in human prostate

  2001cited by this paper
• Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.

  2001cited by this paper
• Paxillin and focal adhesion signalling

  2000cited by this paper
• Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia.

  1994cited by this paper
• Distributed under Creative Commons Cc-by 4.0 a Pilot Study to Investigate If New Zealand Men with Prostate Cancer Benefit from a Mediterranean-style Diet

  year unknowncited by this paper

• The role of RhoA-ROCK signaling in benign prostatic hyperplasia: a review

  2025cites this paper
• Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Escherichia coli

  2024cites this paper
• Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness

  2024cites this paper
• Development of medicinal and cosmetic cream based on flavonoids.

  2024cites this paper
• Plant Phenolics Inhibit Focal Adhesion Kinase and Suppress Host Cell Invasion by Uropathogenic Escherichia coli

  2023cites this paper
• Mechanisms Research on Benign Prostatic Hyperplasia Intervened by Tong Guan Pill Based on Label Free Proteomics

  2023cites this paper
• Combination therapy for benign prostate hyperplasia-related urinary symptoms

  2022cites this paper
• A Combination of Natural Products, BenPros (Green Tea Extract, Soybean Extract and Camellia Japonica Oil), Ameliorates Benign Prostatic Hyperplasia

  2022cites this paper
• Sustainable and effective approach to recover antioxidant compounds from purple tea (Camellia sinensis var. assamica cv. Zijuan) leaves.

  2022cites this paper
• A comprehensive review of the influence of Epigallocatechin gallate on Sjögren's syndrome associated molecular regulators of exocytosis (Review)

  2021cites this paper
• Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia

  2021influential citation
• Epigallocatechin gallate affects the proliferation of human alveolar osteoblasts and periodontal ligament cells, as well as promoting cell differentiation by regulating PI3K/Akt signaling pathway

  2021cites this paper
• Focal adhesion dynamics in cellular function and disease.

  2021cites this paper
• p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.

  2021cites this paper
• Tea polyphenol alleviate Aeromonas hydrophila - induced intestinal physical barrier damage in grass carp (Ctenopharyngodon idella)

  2021cites this paper
• The Effect Of Epigallocatechin-3-Gallate On Transcriptional Regulation Of Migration And Inflammation Related Genes In Benign Prostate Hyperplasia Cells

  2021cites this paper
• Effect of Paecilomyces tenuipes Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Sprague–Dawley Rats

  2019cites this paper
• Identification of key genes and pathways in benign prostatic hyperplasia

  2019cites this paper
• Potential ameliorative effects of epigallocatechin‐3‐gallate against testosterone‐induced benign prostatic hyperplasia and fibrosis in rats

  2018cites this paper